These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 17031387)

  • 21. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
    Buss JL; Neuzil J; Ponka P
    Arch Biochem Biophys; 2004 Jan; 421(1):1-9. PubMed ID: 14678779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy.
    Rajesh M; Sulochana KN; Ramakrishnan S; Biswas J; Manoharan PT
    Curr Eye Res; 2004 Jun; 28(6):399-407. PubMed ID: 15512947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
    Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
    Maurício AQ; Lopes GK; Gomes CS; Oliveira RG; Alonso A; Hermes-Lima M
    Biochim Biophys Acta; 2003 Mar; 1620(1-3):15-24. PubMed ID: 12595068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deferiprone protects against doxorubicin-induced myocyte cytotoxicity.
    Barnabé N; Zastre JA; Venkataram S; Hasinoff BB
    Free Radic Biol Med; 2002 Jul; 33(2):266-75. PubMed ID: 12106822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction.
    Hermes-Lima M; Santos NC; Yan J; Andrews M; Schulman HM; Ponka P
    Biochim Biophys Acta; 1999 Feb; 1426(3):475-82. PubMed ID: 10076064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
    Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
    Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.
    Malisza KL; Hasinoff BB
    Arch Biochem Biophys; 1995 Feb; 316(2):680-8. PubMed ID: 7864623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.
    Hruskova K; Kovarikova P; Bendova P; Haskova P; Mackova E; Stariat J; Vavrova A; Vavrova K; Simunek T
    Chem Res Toxicol; 2011 Mar; 24(3):290-302. PubMed ID: 21214215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
    Horackova M; Ponka P; Byczko Z
    Cardiovasc Res; 2000 Aug; 47(3):529-36. PubMed ID: 10963725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
    Bogdanović G; Kojić V; Dordević A; Canadanović-Brunet J; Vojinović-Miloradov M; Baltić VV
    Toxicol In Vitro; 2004 Oct; 18(5):629-37. PubMed ID: 15251181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
    Becker E; Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide.
    Dhanasekaran A; Kotamraju S; Karunakaran C; Kalivendi SV; Thomas S; Joseph J; Kalyanaraman B
    Free Radic Biol Med; 2005 Sep; 39(5):567-83. PubMed ID: 16085176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
    Hermes-Lima M; Gonçalves MS; Andrade RG
    Mol Cell Biochem; 2001 Dec; 228(1-2):73-82. PubMed ID: 11855743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages.
    Stroh A; Zimmer C; Gutzeit C; Jakstadt M; Marschinke F; Jung T; Pilgrimm H; Grune T
    Free Radic Biol Med; 2004 Apr; 36(8):976-84. PubMed ID: 15059638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cold-induced injury to lung epithelial cells can be inhibited by iron chelators - implications for lung preservation.
    Pizanis N; Gillner S; Kamler M; de Groot H; Jakob H; Rauen U
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):948-55. PubMed ID: 21398140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury.
    Hashimoto T; Ibi M; Matsuno K; Nakashima S; Tanigawa T; Yoshikawa T; Yabe-Nishimura C
    Free Radic Biol Med; 2004 Mar; 36(5):555-64. PubMed ID: 14980700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.